BioNTech SE (BNTX)

122.57 -0.40 (-0.33%)
Close USD Disclaimer
122.57 0.00 (0.00%)

BioNTech SE Company Profile

Sector
Healthcare
Employees
4000
Equity Type
ORD
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Contact Information
Address
Mainz,55131 Germany
Phone
49 6131 9084 0
Fax
49 6131 9084 390
Top Executives
Name
Age
Since
Title
Michael Motschmann 63 2008 Independent Supervisory Board Member
Helmut W. Jeggle 51 2008 Independent Supervisory Board Chairman
Ulrich Wandschneider 61 2018 Independent Deputy Chairman Supervisory Board
Christoph Hubert Huber 79 2008 Co-Founder & Member of Supervisory Board
Rudolf Staudigl 69 2022 Supervisory Board Member
Anja Morawietz 46 2022 Supervisory Board Member
Hans Hengartner 79 0000 Member of Scientific Advisory Board
Rolf M. Zinkernagel 79 0000 Member of Scientific Advisory Board
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles